EpiMethyl Analytics provides a cloud‑based platform that decodes genome‑wide DNA methylation patterns using signal detection, unsupervised machine learning, and high‑performance computing to enable early diagnosis of complex diseases. By analyzing epigenetic signatures, the technology can identify conditions such as cancer, autism spectrum disorder, pediatric leukemia, and type II diabetes before symptoms appear, supporting earlier intervention and improved treatment outcomes. The platform delivers a comprehensive health state assessment rather than targeting a limited set of biomarkers.
Funding
Funding not disclosed
Founders
Product
Problem
Current diagnostic methods often detect complex diseases such as cancer, autism spectrum disorder, and pediatric leukemia only after symptoms appear, limiting treatment options and reducing survival rates. Early molecular changes, particularly DNA methylation patterns, remain untapped for proactive health assessment.
Solution
EpiMethyl Analytics offers a cloud‑based platform that decodes genome‑wide DNA methylation signatures using signal detection and unsupervised machine‑learning algorithms. By analyzing the full epigenome, the system identifies risk markers for a broad range of complex diseases before clinical manifestation. The platform delivers actionable risk reports that enable clinicians to plan preventive interventions, tailor treatment strategies, and improve patient outcomes. Integration with existing clinical workflows allows medical centers and pharmaceutical partners to incorporate epigenetic insights into diagnostics, drug discovery, and early‑treatment protocols.
Target Audience
Primary customers are medical centers, diagnostic laboratories, and pharmaceutical companies seeking early‑detection biomarkers and epigenetic insights for complex diseases.
Features
- Whole‑genome methylation profiling powered by proprietary signal‑processing pipelines
- Unsupervised machine‑learning models that uncover disease‑associated epigenetic networks without prior labeling
- Scalable cloud computing infrastructure for rapid analysis of large patient cohorts
- Automated risk scoring and visual reports that translate epigenetic data into clinically interpretable insights
- API and data export capabilities for integration with electronic health records, research pipelines, and pharmaceutical discovery platforms